Homocysteine, antioxidant micronutrients and late onset dementia

European Journal of Nutrition

Volumn 53, Issue 1, 2014, Pages 277-285

  Whalley, Lawrence J ^a   Duthie, Susan J ^b   Collins, Andrew R ^c   Starr, John M ^d   Deary, Ian J ^d   Lemmon, Helen ^e   Duthie, Ashleigh C ^f   Murray, Alison D ^a   Staff, Roger T ^g  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ROYAL CORNHILL HOSPITAL   (United Kingdom)

^f Royal Dundee Liff Hospital   (United Kingdom)

^g ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dementia; Folate; Homocysteine; Plasma antioxidants; Vitamin B12

Indexed keywords

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BODY MASS INDEX; COGNITION; DEMENTIA; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MICRONUTRIENTS; NUTRITION ASSESSMENT; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; VITAMIN B 12;

EID: 84895074627     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0526-6     Document Type: Article

References (46)

1. Clarke R, Smith AD, Jobst KA, et al. (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 55:1449-1455
2. Seshadri S, Beiser A, Selhub J, et al. (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Eng J Med 346:476-483
3. Ravaglia G, Forti P, Maioli F, et al. (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82:636-643
4. Haan MN, Miller JW, Aiello AE, et al. (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento area Latino study on aging. Am J Clin Nutr 85:511-517
5. Zylberstein DE, Lissner L, Björkelund C, et al. (2011) Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging 32:380-386
6. Wald DS, Kasturirante A, Simmonds M (2011) serum homocysteine and dementia: meta-analysis of eight cohort studies including 8660 participants. Alzheimer's Dementia 7:412-417
7. Kim J-M, Stewart R, Kim S-W, et al. (2008) Changes in folate, vitamin B12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiat 79:864-868
8. Luchsinger JA, Tang M, Shea S, et al. (2004) Plasma homocysteine levels and risk of Alzheimer disease. Neurology 62:1972-1976
9. Yip AG, Brayne C, Matthews FE (2006) MRC cognitive function and ageing study. Risk factors for incident dementia in England and Wales: the medical research council cognitive function and ageing study. A population-based nested case-control study. Age Ageing 35:154-160
10. Stern Y, Gurland B, Tatemichi TK, et al. (1994) Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271:1004-1010
11. Breitner JC, Folstein MF (1984) Familial nature of Alzheimer's disease. N Eng J Med 311:192
12. Farrer LA, Cupples LA, Haines JL, et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356
13. Mielke MM, Rosenberg PB, Tschanz J, et al. (2007) Vascular factors predict rate of progression in Alzheimer disease. Neurology 69:1850-1858
14. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3223-3229
15. Conquer JA, Tierney MC, Zecevic J, et al. (2000) Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35:1305-1321
16. Broekmans WM, Klopping-Ketelaars IA, Schuurman CR, et al. (2000) Fruit and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J Nutrition 130:1578-1583
17. Smith SM, Oliver SAM, Zwart SR, et al. (2006) Nutritional status is altered in the self-neglecting elderly. J Nutrition 136:2534-2541
18. Refsum H, Nurk E, Smit DA, et al. (2006) The hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutrition 136:1731S-1740S
19. Floegel A, Chung SJ, von Ruesten A, et al. (2011) Antioxidant intake from diet and supplements and elevated serum C-reactive protein and plasma homocysteine in US adults: a cross-sectional study. Public Health Nutrition 14:2055-2064
20. Durga J, van Boxel MPJ, Schouten EG, et al. (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FCIT trial: a randomised, double-blind, controlled trial. Lancet 369:208-216
21. Whalley L, Murray AD, Staff RT, et al. (2011) How the 1932 and 1947 mental surveys of Aberdeen schoolchildren provide a framework to explore the childhood origins of late onset disease and disability. Maturitas 69:365-372
22. Deary IJ, Whiteman MC, Starr JM, et al. (2004) The impact of childhood intelligence on later life: following up the Scottish Mental Surveys of 1932 and 1947. J Pers Soc Psychol 86:130-1147
23. Registrar General's Classification of Occupations (1990) Her Majesty's Stationary Office London
24. Carstairs V, Morris R (1991) Deprivation and health in Scotland. Aberdeen University Press, Aberdeen
25. Bolton Smith C, Casey CE, Gey KF, et al. (1991) Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers. Br J Nutr 65:37-346
26. Whalley LJ, Fox HC, Lemmon HA, et al. (2003) Dietary supplement use in old age: associations with childhood IQ, current cognition and health. Int J Geriat Psychiat 18:769-776
27. Finch S, Doyle W, Lowe C, et al. (1998). National diet and nutrition survey: people aged 65 years and over 1. Her Majesty's Stationary Office London
28. Duthie SJ, Whalley LJ, Collins AR, et al. (2002) Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 75:908-913
29. Ross MA (1994) Determination of ascorbic acid and uric acid in plasma by high performance liquid chromatography. J Chromatog 657:197-200
30. Hess D, Keller HE, Oberlin B, et al. (1991) Simultaneous determination of retinol, tocopherols, carotenes and lycopene in plasma by means of high performance liquid chromatography on reversed phase. Int J Vit Nutr Res 61:232-238
31. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
32. International Classification of Diseases, World Health Organisation. http://apps.who.int/classifications/apps/icd/icd10online
33. Writing Group (1998) Medical research council cognitive function and ageing study (MRCCFAS) cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and the prevalence of GMS organicity level in MRC CFA study. Psychol Med 28:319-335
34. Ilzecka J (2003) Total antioxidant status is increased in the serum of amyotrophic lateral sclerosis patients. Scand J Clin Lab Invest 63:297-302
35. Rodrigo R, Prat H, Passalacqua W, et al. (2008) Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond) 114:625-634
36. Karajibani M, Hashemi M, Montazerifar F, et al. (2009) The status of glutathione peroxidase, superoxide dismutase, vitamins A, C, E and malondialdehyde in patients with cardiovascular disease in Zahedan, Southeast Iran. J Nutr Sci Vitaminol (Tokyo) 55:309-316
37. Serra JA, Domínguez RO, Marschoff ER, et al. (2009) Systemic oxidative stress associated with the neurological diseases of aging. Neurochem Res 34:2122-2132
38. Bartosz G (2010) Non-enzymatic antioxidant capacity assays: limitations of use in biomedicine. Free Radical Res 44:711-720
39. Whalley LJ, Starr JM, Athawes R, et al. (2000) Childhood mental ability and dementia. Neurology 55:1455-1459
40. Mielke MM, Rosenberg PR, Tschanz J, et al. (2007) Vascular factors predict rate of progression in Alzheimer disease. Neurology 69:1850-1858
41. Faraci FM, Lentz SR (2004) Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35:345-347
42. Mondragon-Rodriguez S, Basurto-Islas G, Santa-Maria I, et al. (2008) Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. Int J Exp Pathol 89:81-90
43. Kruman II, Kumaravel TS, Lohani A, et al. (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22:752-1762
44. Fuso A, Nicolia V, Pascualato A, et al. (2011) Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol Aging 32:187-199
45. Smith AD, Smith SM, de Jager CA, et al. (2010) Homocysteine lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomised controlled trial. PLoS One 5(9):e12244
46. de Jager CA, Oulhaj A, Jacoby R, et al. (2012) Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomised controlled trial. Int J Geriatr Psychiatry 27:592-600